Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Echocardiography. 2021 Jun 29;38(8):1263–1271. doi: 10.1111/echo.15131

Table 2:

Univariate logistic regression analysis for all-cause mortality

OR 95 % CI P value
Clinical parameters
Age, per unit change 1.2 1.1 - 1.2 <0.0001
Female 2.9 0.8 - 10.4 0.09
AA vs Whites 3.3 0.7 - 15.5 0.13
HTN 3.6 0.8 - 16.9 0.10
DM 2.0 0.6 - 7.2 0.27
CAD 3.2 0.9 - 11.3 0.07
Smoking 0.7 0.2 - 2.6 0.61
CHF 1.6 0.7 - 3.6 0.30
Medications
ASA 2.4 0.7 - 8.5 0.15
Statin 2.9 0.8 - 10.1 0.10
BB 1.1 0.5 - 6.3 0.80
ACEi/ARB 2.2 0.6 - 7.6 0.21
Diuretics 1.2 0.1 - 9.3 0.87
Echocardiogram
LVEF, per unit change 0.9 0.9 - 1.0 0.15
LVEF <35% 1.5 0.3 - 7.8 0.61
ESWS, per unit change 1.0 1.0 - 1.0 0.01
EDWS, per unit change 1.0 0.9 - 1.1 0.38
LV SV, per unit change 0.9 0.9 – 1.0 0.27
LV EDV, per unit change 1.0 0.9 – 1.0 0.97
Coronary Angiogram
3 Vessel dis, % 1.6 0.4 - 6.3 0.48
>50% LM stenosis 14.1 3.5 - 56.8 0.02
Proximal LAD stenosis 0.5 0.1 - 2.6 0.43
LVEDP, per unit change 0.9 0.8 - 1.0 0.34
LVSP, per unit change 1.0 0.9 - 1.1 0.06

AA, African American; HTN, hypertension; DM, diabetes mellitus; CHF, congestive heart failure; CKD, chronic kidney disease; STEMI, ST-elevation myocardial infarction; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; EDWS, end-diastolic wall stress; ESWS, end-systolic wall stress; LVEF, left ventricular ejection fraction; LM, left main; LAD, left anterior coronary artery; LV SV, LV stroke volume; LV EDV, LV end-diastolic volume; LVEDP, LV end-diastolic pressure; LVSP, LV systolic pressure.